Array Biopharma (ARRY) Tops Q1 EPS by 1c

Array Biopharma (NASDAQ: ARRY) reported Q1 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $6.07 million versus the consensus estimate of $6.35 million.

For earnings history and earnings-related data on Array Biopharma (ARRY) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance